BioVaxys Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
November 14, 2023 at 05:48 pm EST
BioVaxys Technology Corp. reported earnings results for the third quarter and nine months ended July 31, 2023. For the third quarter, the company reported net loss was CAD 1.58 million compared to CAD 0.912168 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, net loss was CAD 4.02 million compared to CAD 3.18 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.03 a year ago.